Generic Semaglutide in Canada: 9 Applications Under Review, but the Timeline Is Slipping Health Canada now has 9 generic semaglutide applications under active review from companies including Sandoz, Apotex, Teva, Taro, and Aspen Pharmacare
The primary stance of the two organizations is that, while the observed association between semaglutide and NAION of this study is interesting, more research is warranted to confirm whether the relationship is causal
Lin C, Liu C, Zhang L, Huang Z, Zhao P, Chen R, et al
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: Results of the Binge Eating and Chromium (BEACh) Study
Plus its a cost-effective way to elevate your wellness routine
PlexusDx Precision Peptide Genetic Test ($298) analyzes 14 metabolic pathways and 150+ genetic insights, including your GLP1R variant, GIPR sensitivity, FTO predisposition, and MC4R function